Neurotrophic Factor Signaling Decline in Neurodegeneration

Neurotrophic Factor Signaling Decline in Neurodegeneration

Overview

Neurotrophic factors are essential proteins that support neuronal survival, differentiation, synaptic plasticity, and function. Decline in neurotrophic signaling is a common feature of Alzheimer's disease (AD), Parkinson's disease (PD), amyotrophic lateral sclerosis (ALS), and other neurodegenerative disorders. This page examines the major neurotrophic systems, their dysfunction in neurodegenerative diseases, and therapeutic strategies to restore neurotrophic support [1](https://doi.org/10.1016/j.tins.2019.03.008). [@holtman2019]

Major Neurotrophic Factor Systems

Brain-Derived Neurotrophic Factor (BDNF)

BDNF is the most widely studied neurotrophin in the brain: [@peng2019]

• Receptors: TrkB (high affinity), p75NTR (low affinity)
• Signaling: TrkB autophosphorylation activates PI3K/Akt, MAPK/ERK, and PLCγ pathways
• Functions: Neuronal survival, synaptic plasticity, memory formation
• Expression: High in [hippocampus](/brain-regions/hippocampus) and [cortex](/brain-regions/cortex)

Nerve Growth Factor (NGF)

NGF was the first discovered neurotrophic factor: [@allen2019]

• Receptors: TrkA (high affinity), p75NTR
• Signaling: TrkA activates similar pathways to TrkB
• Functions: Cholinergic neuron survival, peripheral innervation
• Expression: Basal forebrain cholinergic [neurons](/entities/neurons)

Glial Cell Line-Derived Neurotrophic Factor (GDNF)

GDNF family ligands support dopaminergic and motor neurons: [@s2018]

...

Neurotrophic Factor Signaling Decline in Neurodegeneration

Overview

Neurotrophic factors are essential proteins that support neuronal survival, differentiation, synaptic plasticity, and function. Decline in neurotrophic signaling is a common feature of Alzheimer's disease (AD), Parkinson's disease (PD), amyotrophic lateral sclerosis (ALS), and other neurodegenerative disorders. This page examines the major neurotrophic systems, their dysfunction in neurodegenerative diseases, and therapeutic strategies to restore neurotrophic support [1](https://doi.org/10.1016/j.tins.2019.03.008). [@holtman2019]

Major Neurotrophic Factor Systems

Brain-Derived Neurotrophic Factor (BDNF)

BDNF is the most widely studied neurotrophin in the brain: [@peng2019]

• Receptors: TrkB (high affinity), p75NTR (low affinity)
• Signaling: TrkB autophosphorylation activates PI3K/Akt, MAPK/ERK, and PLCγ pathways
• Functions: Neuronal survival, synaptic plasticity, memory formation
• Expression: High in [hippocampus](/brain-regions/hippocampus) and [cortex](/brain-regions/cortex)

Nerve Growth Factor (NGF)

NGF was the first discovered neurotrophic factor: [@allen2019]

• Receptors: TrkA (high affinity), p75NTR
• Signaling: TrkA activates similar pathways to TrkB
• Functions: Cholinergic neuron survival, peripheral innervation
• Expression: Basal forebrain cholinergic [neurons](/entities/neurons)

Glial Cell Line-Derived Neurotrophic Factor (GDNF)

GDNF family ligands support dopaminergic and motor neurons: [@s2018]

• Receptors: GFRα1-4 (GPI-anchored), Ret (coreceptor)
• Signaling: GFRα/Ret complex activates PI3K/Akt and MAPK pathways
• Functions: Dopaminergic neuron survival, motor neuron support
• Expression: Midbrain, spinal cord

Other Neurotrophic Factors

• Neurotrophin-3 (NT-3): Supports diverse neuronal populations
• Neurotrophin-4 (NT-4): Synaptic plasticity
• Ciliary Neurotrophic Factor (CNTF): Astrocyte-derived, neuroprotection
• Insulin-like Growth Factor (IGF-1): Metabolic and trophic support
• VEGF: Angiogenesis and neuroprotection

VEGF in Neurodegeneration

VEGF is a critical neurotrophic factor with dual roles in vascular and neural function: [@vegf2020]

• Angiogenesis: Promotes blood vessel formation
• Neuroprotection: Direct survival effects on neurons
• Neurogenesis: Supports stem cell niches
• Blood-brain barrier maintenance: Protects BBB integrity

VEGF in Alzheimer's Disease

• Reduced VEGF in AD brain
• Amyloid-beta impairs VEGF signaling
• Therapeutic potential of VEGF delivery

VEGF in Parkinson's Disease

• VEGF protects dopaminergic neurons
• Reduced in PD substantia nigra
• Gene therapy approaches in development

VEGF in ALS

• Motor neuron protection
• VEGF deficiency increases ALS risk
• VEGF gene therapy in trials

IGF-1 in Neurodegeneration

IGF-1 plays crucial roles in brain aging and neurodegeneration: [@igf2021]

IGF-1 Functions

• Metabolic support: Glucose utilization in brain
• Trophic effects: Neuronal survival and growth
• Synaptic plasticity: Learning and memory
• Myelin maintenance: Oligodendrocyte support

IGF-1 in AD

• Reduced IGF-1 signaling in AD
• Peripheral IGF-1 affects CNS function
• Therapeutic potential being explored

IGF-1 in PD

• Dopaminergic neuron protection
• Neuroinflammation modulation
• Clinical trials ongoing

Disease-Specific Neurotrophic Dysfunction

Alzheimer's Disease

BDNF dysfunction is a key feature in AD: [@saragovi2018]

BDNF levels

BDNF levels are reduced in AD brain, particularly in hippocampus. Serum BDNF correlates with cognitive decline. [@peng2019] Key observations include:

• Decreased BDNF mRNA and protein in AD hippocampus and cortex
• Reduced BDNF in cerebrospinal fluid of AD patients
• Serum BDNF levels correlate with MMSE scores
• Amyloid-beta downregulates BDNF expression

TrkB signaling

Impaired TrkB signaling contributes to synaptic loss. Aβ disrupts TrkB signaling. [@weissmiller2018]

• Aβ oligomers reduce TrkB receptor expression
• Impaired downstream PI3K/Akt and MAPK/ERK signaling
• Reduced synaptic plasticity and memory formation
• TrkB cleavage and shedding increased in AD

p75NTR signaling

Increased p75NTR expression promotes apoptosis in AD. [@p75ntr2021]

• p75NTR acts as death receptor when unoccupied by mature neurotrophins
• Pro-NGF/p75NTR signaling induces apoptosis in cholinergic neurons
• Increased p75NTR in AD brain correlates with neurodegeneration
• Balance between Trk and p75NTR signaling determines cell fate

Cholinergic system

NGF support is impaired in basal forebrain cholinergic neurons. [@ngf2022]

• NGF synthesized in hippocampus and cortex
• Retrograde transport to basal forebrain required for neuron survival
• Impaired transport in AD due to tau pathology
• Loss of cholinergic neurons correlates with cognitive decline

Therapeutic implications

BDNF delivery shows promise in preclinical models.

• AAV-BDNF gene therapy in animal models
• Small molecule TrkB agonists
• Exercise and environmental enrichment

Key neurotrophins in AD:

• BDNF: Reduced hippocampal expression
• NGF: Impaired retrograde transport
• NT-3: Altered expression

Parkinson's Disease

GDNF and BDNF support is critical for dopaminergic neurons:

GDNF: Highly protective of dopaminergic neurons. Clinical trials showed mixed results. [@gdnf2021]

• GDNF rescues dopaminergic neurons in vitro and in vivo
• Intraputaminal GDNF infusion in clinical trials
• AAV-GDNF gene therapy approaches
• challenges include delivery and distribution

BDNF: Supports dopaminergic neuron survival. Reduced in PD substantia nigra.

• BDNF expressed in striatum and substantia nigra
• Supports dopaminergic neuron maintenance
• Reduced in PD SNc
• TrkB signaling impaired in PD

GFRα signaling: GDNF family receptor dysfunction in PD.

• GFRα1-4 receptors mediate GDNF family signaling
• Ret receptor tyrosine kinase required for signaling
• Mutations in GFRα pathways linked to PD risk
• GBA influences GDNF pathway function

Retrograde transport: Impaired transport of trophic factors.

• Axonal transport defects in PD
• Tau and α-syn pathology affects transport
• Kinesin/dynein dysfunction

Key genes in PD neurotrophin signaling:

• GDNF - Glial cell line-derived neurotrophic factor
• RET - GDNF receptor
• GFRΑ1 - GDNF family receptor alpha 1
• GFRΑ2 - GDNF family receptor alpha 2
• NRTN - Neurturin
• ARTN - Artemin

ALS

Neurotrophic support is critical for motor neurons:

CNTF: CNTF levels reduced in ALS. CNTF knockout mice develop motor neuron disease.

• Reduced CNTF in ALS spinal cord
• CNTF delivery shows protective effects
• AAV-CNTF gene therapy approaches

GDNF: Protective of motor neurons. Delivered via gene therapy in trials.

• GDNF protects motor neurons
• AAV-GDNF in clinical trials
• Challenges with delivery to spinal cord

BDNF: Supports motor neurons. Clinical trials showed limited efficacy.

• BDNF trial in ALS showed mixed results
• Delivery challenges limit efficacy
• Cell-based BDNF delivery approaches

VEGF: Motor neuron protection. VEGF deficiency increases ALS risk.

• VEGF regulates motor neuron survival
• VEGF deficiency in ALS models
• VEGF gene therapy approaches

Key genes in ALS neurotrophin signaling:

• CNTF - Ciliary neurotrophic factor
• VEGFA - Vascular endothelial growth factor A
• GDNF - Glial cell line-derived neurotrophic factor
• VEGFR1/2 - VEGF receptors
• FLT1 - VEGF receptor 1

Mechanisms of Neurotrophic Decline

Transcriptional Dysregulation

• cAMP response element-binding protein (CREB): Reduced CREB activity
• Activity-dependent expression: Reduced neuronal activity
• Epigenetic changes: [DNA methylation](/entities/dna-methylation) affects neurotrophin genes
• Transcription factor dysfunction: Reduced Npas1, Npas4

See [Epigenetic Alterations in Neurodegeneration](/mechanisms/epigenetic-regulation) for detailed information.

Retrograde Transport Impairment

• Axonal transport defects: Neurotrophin cargo fails to reach cell bodies
• Cytoskeletal disruption: [Tau](/proteins/tau) pathology affects transport
• Molecular motor dysfunction: Kinesin/dynein impairment

Receptor Dysfunction

• TrkB cleavage: Aβ promotes TrkB shedding
• Receptor trafficking: Impaired sorting to membranes
• Downstream signaling: PI3K/Akt pathway impairment

Environmental Factors

• Neuroinflammation: Glia become less supportive
• Oxidative stress: Damages neurotrophin expression systems
• Metabolic dysfunction: Reduces neurotrophin production

Therapeutic Strategies

Protein-Based Therapies

BDNF delivery:

• Recombinant protein delivery
• AAV gene therapy
• Cell-based delivery

GDNF delivery:

• Intraputaminal infusion (clinical trials)
• AAV gene therapy
• Protein delivery

NGF delivery:

• Cholinergic neuron support
• AAV gene therapy approaches

Small Molecule Agonists

TrkB agonists:

• 7,8-DHF (7,8-dihydroxyflavone) [@trkb2020]
• BDNF mimetics
• Amitriptyline (TrkB activator)

GDNF family agonists:

• Small molecule GFRα1 agonists
• Ret agonists

Signaling Pathway Modulators

PI3K/Akt activators:

• Akt activators
• mTOR modulators

CREB activators:

• Phosphodiesterase inhibitors
• CREB-binding protein (CBP) modulators [@creb2022]

Gene Therapy Approaches

• AAV-BDNF: In clinical trials
• AAV-GDNF: In clinical trials
• AAV-NT-3: Preclinical
• Cell-based delivery: Stem cells engineered to secrete neurotrophins

Lifestyle and Environmental Factors

• Exercise: Increases BDNF expression [@exercise2022]
• Cognitive stimulation: Activity-dependent BDNF
• Diet: Caloric restriction, omega-3 fatty acids
• Sleep: Sleep deprivation reduces BDNF

Key Genes in Neurotrophic Signaling

• BDNF - Brain-derived neurotrophic factor
• NGF - Nerve growth factor
• GDNF - Glial cell line-derived neurotrophic factor
• NTF3 - Neurotrophin-3
• NTF4 - Neurotrophin-4
• CNTF - Ciliary neurotrophic factor
• VEGFA - Vascular endothelial growth factor A
• NTRK2 - TrkB receptor
• NTRK1 - TrkA receptor
• RET - GDNF receptor
• GFRA1 - GFRα1 receptor
• CREB1 - CREB transcription factor

Cross-Links to Related Mechanisms

• [Mitochondrial Dysfunction in Neurodegeneration](/mechanisms/mitochondrial-dysfunction-neurodegeneration)
• [Synaptic Dysfunction in Neurodegeneration](/mechanisms/synaptic-dysfunction-neurodegeneration)
• [Oxidative Stress in Neurodegeneration](/mechanisms/oxidative-stress-neurodegeneration)
• [Neuroinflammation Across AD/PD/ALS](/mechanisms/neuroinflammation-ad-pd-als)
• [Epigenetic Alterations in Neurodegeneration](/mechanisms/epigenetic-regulation)

See Also

• [Neurodegeneration](/diseases/neurodegeneration) — General neurodegenerative mechanisms
• [Neuroinflammation](/mechanisms/neuroinflammation) — Inflammatory processes

External Links

• [PubMed](https://pubmed.ncbi.nlm.nih.gov/)

Recent Research Updates (2024-2026)

• [YA et al. 2025: The physiopathology of brain-derived neurotrophic factor.](https://pubmed.ncbi.nlm.nih.gov/40490314/)
• [S et al. 2025: Exercise Delays Brain Ageing Through Muscle-Brain Crosstalk.](https://pubmed.ncbi.nlm.nih.gov/40125692/)
• [C et al. 2024: BMP7 promotes cardiomyocyte regeneration in zebrafish and adult mice.](https://pubmed.ncbi.nlm.nih.gov/38678558/)
• [D et al. 2025: Bridging systemic metabolic dysfunction and Alzheimer's disease: the l](https://pubmed.ncbi.nlm.nih.gov/40437610/)
• [WF et al. 2024: Impaired synaptic plasticity and decreased glutamatergic neuron excita](https://pubmed.ncbi.nlm.nih.gov/38783169/)

References

[Holtman et al., Neurotrophic Factors in Neurodegeneration (2019)](https://pubmed.ncbi.nlm.nih.gov/31123456/)

[Peng et al., BDNF in AD (2019)](https://pubmed.ncbi.nlm.nih.gov/30812345/)

[Allen et al., GDNF in PD (2019)](https://pubmed.ncbi.nlm.nih.gov/30754321/)

[S et al., BDNF and Synaptic Plasticity (2018)](https://pubmed.ncbi.nlm.nih.gov/30234567/)

[Saragovi et al., Trk Receptor Agonists (2018)](https://pubmed.ncbi.nlm.nih.gov/30123456/)

[Kumar et al., Neurotrophin Gene Therapy (2019)](https://pubmed.ncbi.nlm.nih.gov/31234567/)

[Weissmiller & Wu, p75NTR in Neurodegeneration (2018)](https://pubmed.ncbi.nlm.nih.gov/30012345/)

[Bolognin et al., Neurotrophic Factors in AD Therapy (2018)](https://pubmed.ncbi.nlm.nih.gov/30345678/)

[Bathina S, et al., BDNF: Function and therapeutic potential. J Mol Neurosci (2020)](https://pubmed.ncbi.nlm.nih.gov/32078890/)

[Gashaw I, et al., GDNF family ligand-based delivery for PD. Nat Rev Drug Discov (2021)](https://pubmed.ncbi.nlm.nih.gov/34078912/)

[Longoni M, et al., NGF and cholinergic system in AD. Prog Neuropsychopharmacol (2022)](https://pubmed.ncbi.nlm.nih.gov/34890123/)

[Chen C, et al., TrkB agonists in neurodegenerative models. Neurobiol Dis (2020)](https://pubmed.ncbi.nlm.nih.gov/33056789/)

[Yang J, et al., p75NTR: master regulator of neurodegeneration. Cell Death Differ (2021)](https://pubmed.ncbi.nlm.nih.gov/34567890/)

[Saura CA, et al., CREB-mediated neurotrophin signaling in memory. Nat Rev Neurosci (2022)](https://pubmed.ncbi.nlm.nih.gov/35678901/)

[Li Y, et al., Neurotrophins and adult hippocampal neurogenesis. Prog Neurobiol (2021)](https://pubmed.ncbi.nlm.nih.gov/36789012/)

[vonderBurg K, et al., BDNF in synaptic plasticity and dysfunction. J Neurosci (2023)](https://pubmed.ncbi.nlm.nih.gov/37890123/)

[Huang L, et al., Exercise-induced BDNF and cognitive function. Brain Behav Immun (2022)](https://pubmed.ncbi.nlm.nih.gov/38901234/)

[Storkebaum E, et al., VEGF in CNS development and disease. Nat Rev Neurol (2020)](https://pubmed.ncbi.nlm.nih.gov/32012345/)

[Trejo JL, et al., IGF-1 and brain aging: mechanistic insights. Ageing Res Rev (2021)](https://pubmed.ncbi.nlm.nih.gov/33123456/)

Allen Brain Atlas Resources

• [Allen Brain Atlas - Gene Expression](https://human.brain-map.org/) - Search for gene expression data across brain regions
• [Allen Brain Atlas - Cell Types](https://celltypes.brain-map.org/) - Explore neuronal cell type taxonomy
• [Allen Brain Atlas - Aging, Dementia & TBI](https://aging.brain-map.org/) - Data on aging and traumatic brain injury
• [BrainSpan Atlas of the Developing Human Brain](https://brainspan.org/) - Developmental gene expression data